The World Health Organization’s (WHO) approval of Pfizer’s vaccine clears the way for making this vaccine available to developing and poor countries as well.
Mumbai| In the midst of the Coronavirus crisis, the World Health Organization has approved the emergency use of Pfizer and BioNTech’s coronavirus vaccine. A vaccine has been recognized by the World Health Organization (WHO) for the first time since the outbreak of the corona epidemic. The WHO decision has opened the way for countries around the world to use the vaccine. Pfizer’s vaccine is already in use in many countries.
The World Health Organization’s approval of Pfizer’s vaccine means that now these vaccines will be available to poor countries as well. Until now, these vaccines were available only in Europe and North America. Drug regulatory agencies of countries approve any Covid-19 vaccine on their behalf, but countries with weak systems usually depend on the WHO for this.
The WHO said on Thursday that its decision to approve the emergency use of Covid-19 vaccines would give countries an opportunity to speed up the approval process of their regulators to import and administer vaccines. He said that the vaccine produced by Pfizer-BioNotech has met the safety standards and other parameters set by the organization.
Significantly, many countries including the US, UK and European Union have approved this vaccine. This vaccine has to be kept at a very low temperature, which is a major challenge for developing countries.
The Committee of Experts of the Central Drugs Standard Control Organization (CDSCO) considered the request of the Serum Institute of India to allow the emergency use of the Covid-19 vaccine at Oxford University and India Biotech’s request to allow emergency use of ‘Covaxin’. They had a meeting on Wednesday and now this committee will meet again today i.e. January 1. The expert committee on Covid-19 analyzed additional details submitted by Serum Institute of India and Bharat Biotech. The Health Ministry said in a statement that the committee met later this afternoon to consider the request of Serum Institute of India, Pfizer and Bharat Biotech Pvt Ltd to allow emergency use of vaccines. It said that the committee would meet again on 1 January 2021.